Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program endorsed by ISBER. This testing program is an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods. The Radboud Biobank participated in the program for viable PBMC isolation and the program for cell free DNA Extraction from whole blood. Stabilized whole blood received from IBBL was processed by the Radboud Laboratory for Diagnostics by our standard procedure followed by the cfDNA extraction performed by the Genetics department. The PBMCs were isolated from donor blood by the Laboratory of Medical Immunology with the AutoMACS.
DNA and PBMCs where sent back to IBBL for the analysis. Recently we received the reports of the Proficiency tests which resulted in a quality certificate for both methods. The participants’ mean (n=11 cfDNA and n=53 PBMC) is considered as the assigned value and basic statistics were performed.
If you are interested in the methods or report in more detail, please contact the Radboud Biobank.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

New template available for participant information and informed consent
21 October 2025The new Radboud Biobank template Participant Information Form (PIF) and Informed Consent (IC) for biobank collections is based on the standard developed within the NFU Mutual Recognition project.
go to page
Radboudumc Researchers Highlight Critical Gaps in Reporting Pre-Analytical Processes in Biobanked Biomaterials
21 October 2025Radboudumc Researchers have identified significant shortcomings in pre-analytical sample processing reporting in clinical biomarker research, a factor crucial for study reliability and replicability.
go to page
The National Biobanks & Collections Day
21 October 2025On Thursday, March 19, 2026, the third edition of the National Biobanks & Collections Day will be organized in Utrecht at the Princess Máxima Center for Pediatric Oncology.
go to page
First implications of the Radboud Biobank new business model
15 July 2025It was communicated in an earlier news item that the Radboudumc Board of Directors decided to change the Radboud Biobank business model.
go to page
Relocation of Radboud Biobank samples to Central Freezing Facility
15 July 2025The Radboud Biobank has now transferred almost all stored samples to the central freezing facility.
go to page
Standardized Radboud Biobank procedures for sample handling in Elabgids
15 July 2025The Radboud Biobank is currently preparing to include all standardized Radboud Biobank procedures for sample handling in the eLabgids.
go to page